Organization, Operations and Liquidity (Tables)

9 Months Ended

Sep. 30, 2012

Organization, Operations and Liquidity [Abstract]

Product Development Pipeline

Our product development pipeline is summarized in the table below:

Product Candidate (Indication) Androxal®	Status	Next Expected Milestone(s)
Secondary Hypogonadism	Phase 3	Complete first Phase 3 pivotal study (Q2 2013) Complete open label safety study (Q4 2013) Complete DEXA study (Q1 2014)
Proellex®
Uterine Fibroids	Phase 2	Complete Phase 2 study (vaginal delivery) (Q4 2012)
Endometriosis	Phase 2	Initiate Phase 2 study (oral delivery) (Q4 2012)